P. Home

发表

Insulin glargine in combination with nateglinide in people with Type 2 diabetes: a randomized placebo‐controlled trial

U. Dashora, L. Sibal, S. Ashwell, 2007, Diabetic medicine : a journal of the British Diabetic Association.

L. Heinemann, P. Home, M. Hompesch, 2015, Diabetes, obesity & metabolism.

The pharmacokinetics and pharmacodynamics of rapid‐acting insulin analogues and their clinical consequences

P. D. Home, P. D. Home, Philip Home, 2012, Diabetes, obesity & metabolism.

Insulin aspart vs. human insulin in the management of long‐term blood glucose control in Type 1 diabetes mellitus: a randomized controlled trial

A. Lindholm, P. Home, A. Riis, 2000, Diabetic medicine : a journal of the British Diabetic Association.

Self-monitoring of blood glucose in type 2 diabetes: Steps toward consensus [2]

R. Colagiuri, S. Colagiuri, Ambady Ramachandran, 2007 .

Twice‐daily compared with once‐daily insulin glargine in people with Type 1 diabetes using meal‐time insulin aspart

S. Ashwell, P. Home, J. Gebbie, 2006, Diabetic medicine : a journal of the British Diabetic Association.

Optimal timing of injection of once‐daily insulin glargine in people with Type 1 diabetes using insulin lispro at meal‐times

S. Ashwell, J. Gebbie, P. Home, 2006, Diabetic medicine : a journal of the British Diabetic Association.

Identifying the impact of diabetes research

M. Buxton, P. Home, J. Grant, 2006, Diabetic medicine : a journal of the British Diabetic Association.

Consensus guidelines for the management of insulin-dependent (TYPE 1) diabetes

R. Heine, M. Massi-Benedetti, M. Porta, 1993 .

Doubts about DOTS

S. Ross, J. McLay, Philip Home, 2008, BMJ : British Medical Journal.

Cancer outcomes and all-cause mortality in adults allocated to metformin: systematic review and collaborative meta-analysis of randomised clinical trials

A. Farmer, R. Holman, R. Ali, 2012, Diabetologia.

Rosiglitazone RECORD study: glucose control outcomes at 18 months

M. Hanefeld, S. Pocock, M. Komajda, 2007, Diabetic medicine : a journal of the British Diabetic Association.

Rosiglitazone Evaluated for Cardiac Outcomes and Regulation of Glycaemia in Diabetes (RECORD): study design and protocol

M. Hanefeld, S. Pocock, M. Komajda, 2005, Diabetologia.

Plasma insulin profiles after subcutaneous injection: how close can we get to physiology in people with diabetes?

P. D. Home, Philip Home, P. Home, 2015, Diabetes, obesity & metabolism.

One-year sustained glycaemic control and less hypoglycaemia with new insulin glargine 300 U/ml compared with 100 U/ml in people with type 2 diabetes using basal plus meal-time insulin: the EDITION 1 12-month randomized trial, including 6-month extension

M. Riddle, H. Yki-Järvinen, G. Bolli, 2015, Diabetes, obesity & metabolism.

New insulin glargine 300 U/ml compared with glargine 100 U/ml in insulin-naïve people with type 2 diabetes on oral glucose-lowering drugs: a randomized controlled trial (EDITION 3)

R. Bergenstal, M. Riddle, G. Bolli, 2015, Diabetes, obesity and metabolism.

Plasma glucose and hypoglycaemia following exercise in people with Type 1 diabetes: a comparison of three basal insulins

T. Heise, P. Home, S. Dellweg, 2009, Diabetic medicine : a journal of the British Diabetic Association.

A randomized multicentre trial of insulin glargine compared with NPH insulin in people with type 1 diabetes

P. Home, A. Dressler, R. Rosskamp, 2005, Diabetes/metabolism research and reviews.

Insulin Injection Site Tissue Depths and Localization of a Simulated Insulin Bolus Using a Novel Air Contrast Ultrasonographic Technique in Insulin Treated Diabetic Subjects

A. Coulthard, J. Thow, P.D. Home, 1992, Diabetic medicine : a journal of the British Diabetic Association.

Morphology of Palpably Abnormal Injection Sites and Effects on Absorption of Isophane(NPH) Insulin

P. Home, R. Taylor, J. Thow, 1990, Diabetic medicine : a journal of the British Diabetic Association.

Different Absorption of Isophane (NPH) Insulin from Subcutaneous and Intramuscular Sites Suggests a Need to Reassess Recommended Insulin Injection Technique

G. Fulcher, J. Thow, P. D. Home, 1990, Diabetic medicine : a journal of the British Diabetic Association.

Comment on: Nauck MA, Duran S, Kim D et al (2007) A comparison of twice-daily exenatide and biphasic insulin aspart in patients with type 2 diabetes who were suboptimally controlled with sulfonylurea and metformin: a non-inferiority study. Diabetologia 50:259–267

P. Home, P. Home, 2007, Diabetologia.

Premixed insulin aspart 30 vs. premixed human insulin 30/70 twice daily: a randomized trial in Type 1 and Type 2 diabetic patients

B. Boehm, A. Lindholm, N. Kamp, 2002, Diabetic medicine : a journal of the British Diabetic Association.

The challenge of poorly controlled diabetes mellitus.

P. Home, P. Home, 2003, Diabetes & metabolism.

Intensive insulin therapy in clinical practice

P. D. Home, Philip Home, P. Home, 1997, Diabetologia.

Primary-care observational database study of the efficacy of GLP-1 receptor agonists and insulin in the UK

A. McMahon, P. Home, G. Hall, 2013, Diabetic medicine : a journal of the British Diabetic Association.

Meta‐analysis of individual patient data to assess the risk of hypoglycaemia in people with type 2 diabetes using NPH insulin or insulin glargine

S. Schinzel, Andreas Fritsche, Massimo Massi-Benedetti, 2010, Diabetes, obesity & metabolism.

Relationship of glycaemic control and hypoglycaemic episodes to 4‐year cardiovascular outcomes in people with type 2 diabetes starting insulin

N. Freemantle, P. Home, F. Calvi-Gries, 2015, Diabetes, obesity & metabolism.

Glycaemic control and hypoglycaemia with insulin glargine 300U/mL versus insulin glargine 100U/mL in insulin-naïve people with type 2 diabetes: 12-month results from the EDITION 3 trial.

R. Bergenstal, M. Riddle, G. Bolli, 2017, Diabetes & metabolism.

The vexed question of hypoglycaemia and health economics

P. D. Home, P. Home, 2014, Diabetes, obesity & metabolism.

A comparison of intermediate and long-acting insulins in people with type 2 diabetes starting insulin: an observational database study

P. Home, J. Gordon, P. McEwan, 2010, International journal of clinical practice.

Modulation of insulin dose titration using a hypoglycaemia-sensitive algorithm: insulin glargine versus neutral protamine Hagedorn insulin in insulin-naïve people with type 2 diabetes

C. Mathieu, M. Riddle, G. Bolli, 2014, Diabetes, obesity & metabolism.

A double-blind randomized study comparing the effects of continuing or not continuing rosiglitazone + metformin therapy when starting insulin therapy in people with Type 2 diabetes

P. Home, C. Bailey, M. Stewart, 2007, Diabetic medicine : a journal of the British Diabetic Association.

Meta‐analysis of individual patient data to assess the risk of hypoglycaemia in people with type 2 diabetes using NPH insulin or insulin glargine

M. Massi-Benedetti, A. Fritsche, P. Home, 2010, Diabetes, obesity and metabolism.

Improved glycaemic control with insulin glargine plus insulin lispro: a multicentre, randomized, cross‐over trial in people with Type 1 diabetes

S. Heller, R. Bilous, D. Hepburn, 2006, Diabetic medicine : a journal of the British Diabetic Association.